HH GLOBAL LIMITED
Company number 04680562 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment — HH GLOBAL LIMITED
Company No. 04680562 · Holding company (SIC 64209) · Incorporated 27 February 2003
A note before we begin: what I can and cannot see
A financial health check is only as good as the vital signs available. For this company, the data provided covers corporate structure, governance, ownership and filing compliance — but contains no balance sheet, no profit and loss figures, no cash flow, and no turnover. There is no "blood panel" to read.
So this assessment is, by necessity, a structural and governance examination rather than a full financial one. I have graded it accordingly and flagged clearly where the diagnosis is blind. This is a diagnostic opinion based on public record data — it is not an audit and should not be relied on as formal professional advice.
1. Financial Health Score
Grade: B (Provisional) — "Structurally fit, financially unmeasured"
| Dimension | Grade | Comment |
|---|---|---|
| Compliance & filing health | A | Nothing overdue; filings current |
| Governance & board strength | A− | Nine active directors including regional CEOs |
| Ownership & control clarity | A | Unambiguous control, no disputes evident |
| Capital adequacy (this entity) | C | £101 nominal share capital — thin, but normal for a holdco |
| Financial condition (liquidity, solvency, profitability) | Incomplete | No data available |
Why B and not higher: A holding company's financial health is fundamentally a question of the value, liquidity and recoverability of its investments in subsidiaries, and of the strength of its parent. None of that can be verified from the data supplied.
Why B and not lower: There are genuinely no symptoms of distress. The company is active, solvent on the register, fully compliant, mature (22+ years), and sits inside a large, well-established global group.
2. Key Vital Signs
Think of these as the readings on the monitor at the bedside.
| Vital Sign | Reading | What it tells us |
|---|---|---|
| Corporate pulse | Status: Active. Not in liquidation, administration or receivership. | The patient is alive and functioning. No resuscitation events on record. |
| Blood pressure (compliance) | Accounts not overdue. Confirmation statement not overdue. | Normal. No compliance strain, no penalty risk building. |
| Temperature (distress markers) | No insolvency history, no overdue filings, no director disqualification records. | No fever. These are the classic early warning signs of corporate illness, and none are present. |
| Blood panel (balance sheet) | Not available. | Cannot assess liquidity, gearing, net assets or working capital. This is the single biggest gap. |
| Heart (cash flow) | Not available. | Cannot assess whether the business generates or consumes cash. |
| Skeleton (capital structure) | Share capital £101. | Nominal. Typical of an intermediate holding company — funding flows through intercompany loans and group equity, not share capital. Not a red flag, but it means this entity's balance sheet is essentially a mirror of the group's. |
| Genetic profile (ownership) | HH Global Group Limited owns >75% of shares and voting rights and can appoint/remove directors. name shown to subscribers holds 50–75% personally. | Tight, unambiguous control. No evidence of shareholder deadlock or contested ownership — a common cause of corporate arrhythmia. |
| Nervous system (governance) | Nine current directors, including a CEO for EMEA, a CEO for Asia Pacific & India, and a Technical Director. | A strong, functioning board with real operational leadership. Not a "one-person" structure. |
| Age & longevity | Incorporated 2003; renamed from H H Associates (Holdings) Limited in 2013. | Mature. Well past the fragile start-up years — most corporate mortality occurs in the first five years. |
| Immune status (audit) | Audit Exemption Subsidiary. | The company does not stand on its own immunity — it borrows it from the parent. Audit exemption for a subsidiary requires a parent guarantee of liabilities. This is legal and common, but it means this entity's financial protection is only as strong as its parent's. |
| Metabolism (business model) | Website describes a "tech-enabled creative production and procurement partner" operating globally. | A services/procurement intermediary model — typically asset-light, fee-based, and working-capital intensive rather than capital intensive. |
One anomaly worth a second look: The accounts are made up to 31 March 2025, but the next filing is shown as due 31 December 2026 — a 21-month window, longer than the standard nine months for a private company. This may reflect a change of accounting reference date or simply a data artefact. It is not a red flag, but it should be verified rather than assumed.
3. Diagnosis
The patient is a corporate holding company — a "structural" entity rather than an operating one. Its job is to own and control the group's trading subsidiaries, not to generate revenue directly. That shapes everything about how it should be assessed.
What the data reveals:
- Good structural health. The company shows none of the classic symptoms of corporate distress: no insolvency events, no overdue filings, no disqualification records, no ownership disputes, no board vacuum. Its compliance record is clean and its governance is robust.
- Clear, concentrated control. A single group entity holds over 75% of shares and voting rights, with an individual holding a majority stake alongside. Concentrated ownership can be a strength (decisive, long-term decision-making) or a risk (key-person dependency). Here, the presence of a nine-person board with regional CEOs mitigates the key-person risk considerably.
- Maturity and stability. Twenty-two years of continuous registration, with a rebrand in 2013 consistent with the group's expansion into a global brand.
- The critical blind spot. Because this is an audit-exempt subsidiary, its own filed accounts may be abbreviated, and its financial condition is inseparable from that of the wider group. The health of this company is, in practice, the health of HH Global Group. If the group's trading subsidiaries suffer, this entity's investments impair; if the group's cash flow tightens, this entity's intercompany funding tightens with it.
In plain terms: the skeleton, nervous system and circulation of this entity look sound. But we have not drawn the blood, and for a holding company, the blood is the group.
4. Recommendations
Priority 1 — Obtain the missing vital signs. Pull the full statutory accounts for this company and the consolidated accounts of HH Global Group Limited. Specifically look for: net assets, intercompany debtor/creditor balances, going concern statements, and any parent guarantee disclosures. Without these, no meaningful solvency opinion is possible.
Priority 2 — Assess the parent, not just the subsidiary. Because audit exemption is being claimed as a subsidiary, the parent guarantee is the safety net. Test the parent's balance sheet strength, gearing and covenant position. A holding company cannot be healthier than the group it sits inside.
Priority 3 — Verify the accounts filing anomaly. Confirm the accounting reference date and the actual filing deadline with Companies House. If a period has been extended, understand why.
Priority 4 — Monitor governance turnover. One director resigned in October 2026. A single resignation is routine; a pattern of departures — particularly of finance or regional leadership — would be an early symptom worth investigating.
Priority 5 — Track PSC and confirmation statement updates. Ownership above 75% carries obligations and consequences. Any change in the PSC register (a sale, a new investor, a restructuring) would materially alter this assessment.
Priority 6 — If you are a creditor, supplier or lender: Do not rely on this entity's standalone accounts. Request group-level financial information, confirm the existence and scope of the parent guarantee, and consider whether your exposure is really to the group rather than to this company.
Lifestyle advice for the company itself: keep filings current (it is doing so), maintain board breadth, and ensure intercompany arrangements are documented on arm's-length terms — a common source of hidden risk in holding structures.